NASDAQ:MRVI Maravai LifeSciences Q3 2026 Earnings Date & Estimates $7.57 +0.37 (+5.14%) Closing price 10/21/2026 04:00 PM EasternExtended Trading$7.46 -0.11 (-1.51%) As of 06:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Maravai LifeSciences is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Maravai LifeSciences in Q3 2026Maravai LifeSciences is expected to post earnings of -$0.0563 per share on revenue of $43.56 million. In the same quarter a year earlier Maravai LifeSciences reported -$0.08 per share on revenue of $41.63 million. Maravai LifeSciences last reported on August 6, 2026, posting -$0.02 per share and beating the -$0.0435 consensus estimate. Maravai LifeSciences has beaten the consensus EPS estimate in 3 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.0563Expected Revenue$43.56 millionPrior-Year EPS-$0.08Prior-Year Revenue$41.63 millionExpected Revenue Growth+4.6%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.02 (Beat by +$0.0235)Last Quarter Revenue$51.44 millionEPS Beat Rate3 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Maravai LifeSciences Q3 2026 Earnings FAQ When does Maravai LifeSciences report Q3 2026 earnings? Maravai LifeSciences (NASDAQ:MRVI) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Maravai LifeSciences' Q3 2026 earnings call? Maravai LifeSciences' Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Maravai LifeSciences? Analysts expect Maravai LifeSciences to post earnings of -$0.0563 per share for Q3 2026. How much revenue is Maravai LifeSciences expected to report? The consensus revenue estimate for Maravai LifeSciences is $43.56 million for Q3 2026. Maravai LifeSciences Earnings HeadlinesMaravai LifeSciences (MRVI) Stock Gets Fair Value Boost On mRNA And CleanCap OptimismOctober 17, 2026 | finance.yahoo.comMaravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026October 14, 2026 | marketscreener.comMThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade. This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan.October 22 at 1:00 AM | Base Camp Trading (Ad)What Is Maravai’s (MRVI) Comeback Really Worth to Investors?October 4, 2026 | insidermonkey.comMaravai's TriLink Gets New China Patent for CleanCap TechnologySeptember 29, 2026 | marketscreener.comMTriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IPSeptember 29, 2026 | businesswire.comSee More Maravai LifeSciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Maravai LifeSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Maravai LifeSciences and other key companies, straight to your email. Email Address About Maravai LifeSciencesMaravai LifeSciences (NASDAQ:MRVI) is a life sciences company that provides products and services used in the development, manufacture and quality testing of biopharmaceuticals, vaccines and diagnostic products. The company serves pharmaceutical, biotechnology, academic and other research organizations involved in nucleic acid and biologics development. Through its TriLink BioTechnologies business, Maravai supplies specialized nucleic acid products and services, including modified nucleotides, messenger RNA-related materials, enzymes and other components used in research and biomanufacturing. Its offerings support applications such as gene therapy, mRNA development, vaccine research and molecular diagnostics. Maravai also operates through Cygnus Technologies, which provides biologics safety testing products and services. These include analytical assays and impurity testing tools used to identify residual host-cell proteins and other process-related impurities in biologic drug manufacturing. Headquartered in San Diego, California, the company serves customers in the United States and international markets.View Maravai LifeSciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles SpaceX Earnings Launch: High Margins Fund AI AmbitionsGM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?Synchrony Aces The Quarter As Credit Fears FadeHigher Rates Are Sending Investors to These 3 Dividend KingsServiceNow Orchestrates AI's Next Act—Can Earnings Deliver?Swiping to Record Highs: Why Visa Remains a FortressDrone Stocks Have Burned Investors—Are These 4 Different? Upcoming Earnings ENI (10/23/2026)SLB (10/23/2026)American Express (10/23/2026)Infosys (10/23/2026)Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
